DN
Therapeutic Areas
Nanospectra Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AuroLase Therapy | Localized, low- to intermediate-risk Prostate Cancer | Phase 3 |
| Drug | Indication | Phase |
|---|---|---|
| AuroLase Therapy | Localized, low- to intermediate-risk Prostate Cancer | Phase 3 |